Interest of Intravaginal Electro-stimulation at Home by GYNEFFIK® Compared to Usual Care in Incontinent Patients With Prior Perineal Reeducation

Phase 4UnknownNCT02029027

Effik163 enrolled

Overview

The aim of this study is to assess the benefit of GYNEFFIK®, a perineal electro-stimulator, during this home-care phase. Women with stress urinary incontinence (UI) or with mixed UI (composed predominantly of stress UI), that responded to physiotherapy were included in this study in two parallel groups. The groups followed a self-reeducation program, with or without GYNEFFIK® electro-stimulation sessions. The comparison of the two groups was based on the rate of women for whom the benefit of the initial perineal reeducation was maintained.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

163

Conditions

Urinary Stress Incontinence Urinary Mixed Incontinence

Interventions

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * out-patient over 18 years old, having understood and signed the Informed Consent Form * seen for urinary stress incontinence or urinary mixed incontinence (with a major stress incontinence part) troubles * spontaneously asking for help * who can be followed for a long time Exclusion Criteria: * Urinary Incontinence (UI) found out during medical interviewing without spontaneous complaint * Urinary troubles due to neurological pathology (stroke, multiple sclerosis, ...) * UI due to congenital malformation * UI having led to surgery * UI treated in the last 6 months * UI within 24 weeks of Past Partum * Pelvic surgery within 12 months * On-going inflammatory or infectious neoplastic disease * Perineal hypoesthesia * Local conditions prohibiting the use of an intra-vaginal device (vaginal atrophia, continuous metrorrhagia, vaginal prolapse \> 2°, ...) * Pacemaker use * Women of child bearing potential without effective method of contraception or planning to get pregnant in the next 12 months * Intravaginal contraception * Mental impairment or inability to understand or follow study instructions * Patient who may not come back to the study visits * Patient already enrolled for another study or having been enrolled in another clinical study in the past 3 months

Outcomes

Primary Outcomes

Non-Worsening of ICIQ + Ditrovie Scales' Scores

The primary outcome is defined as the non worsening of the ICIQ (International Consultation on Incontinence modular Questionnaire) scale's score AND the DITROVIE scale's score (a specific scale to evaluate the perturbation of the quality of life during urinary troubles). The scores will be considered as maintained if they didn't increase more than 10% with the following calculation: ICIQ variation (%) = 100 x (ICIQ\_M6 - ICIQ\_D0)/ICIQ\_D0 DITROVIE variation (%) = 100 x (DITROVIE\_M6 - DITROVIE\_D0)/(DITROVIE\_D0 -10)

Time frame: 6 Months (or last measurement if premature ending)

Secondary Outcomes

ICIQ Score

Quantitative analyses: * difference = ICIQ\_M6 - ICIQ\_D0 * variation (%)= 100 x (ICIQ\_M6 - ICIQ\_D0)/ICIQ\_D0 Qualitative analysis \* % of patients with a variation % \<-10%, between -10% and +10%, \>10%

Time frame: 6 Months (or last measurement if premature ending)

DITROVIE Score

Quantitative analyses: * difference = DITROVIE\_M6 - DITROVIE\_D0 * variation (%)= 100 x (DITROVIE\_M6 - DITROVIE\_D0)/(DITROVIE\_D0 - 10) Qualitative analysis \* % of patients with a variation % \<-10%, between -10% and +10%, \>10%

Time frame: 6 Months (or least measurement if premature ending)

ICG score

The ICG (clinical global impression) score is the subjective impression of the patient regarding the evolution of her own clinical condition. It will be determined between inclusion and M6 (or the last visit).

Time frame: 6 Months (or last measurement if premature ending)

SF-12 Health Survey (Medical Outcomes Study Short-Form General Health Survey)

Difference = M6 -D0 Variation % = 100 x (M6 - D0)/D0

Time frame: 6 Months (or last measurement if premature ending)

HAD (Hospital Anxiety and Depression) scale

Qualitative analysis: * improvement from sub-score \> 10 to sub-score \< 10 * no change * worsening from sub-score \< 10 to sub-score \> 10

Time frame: 6 months (or last measurement if premature ending)

Bladder diary

A bladder diary will be filled by the patient for 3 days before the inclusion visit and then for 3 days before the final visit. The following items will be compared between D0 and M6: normal urinary episodes, incontinence episodes and drinks, in number and volume. Difference = M6 - D0 Variation % = 100 x (M6-D0)/D0

Time frame: 6 Months (or last visit if premature ending)

Interest of Intravaginal Electro-stimulation at Home by GYNEFFIK® Compared to Usual Care in Incontinent Patients With Prior Perineal Reeducation

Overview

Conditions

Interventions

Eligibility

Locations (1)

Outcomes

Primary Outcomes

Secondary Outcomes